Starting Weight-Loss Injections in India? Questions to Ask Your Doctor

Weight-loss injections have changed the way obesity can be treated medically. Medicines such as semaglutide and tirzepatide can help eligible patients lose weight, but choosing a treatment involves more than comparing medicines or looking at other people’s results.

Before starting, you need to understand whether prescription GLP-1 weight-loss medication is appropriate for you, what your doctor should assess, which side effects to watch for, and how your progress will be monitored. You should also know what treatment may cost and what happens if you need to change or stop the medication.

India’s 2025 clinical practice guideline update from the Endocrine Society of India addresses anti-obesity pharmacotherapy, medication counselling, and the importance of individualised care. The guidance reinforces that treatment decisions should consider the patient’s health profile, expected benefits, risks, and affordability.

If you are considering GLP-1 weight-loss treatment, these are the questions worth discussing with your doctor before your first dose.

1. Am I eligible for weight-loss injections if I don’t have Diabetes?

Some weight-loss injections are approved for chronic weight management in eligible adults without diabetes. However, GLP-1 eligibility depends on the specific medicine, its approved indication, and your individual health profile.

For example, Lilly India’s published information for Mounjaro (tirzepatide) describes its use for chronic weight management in adults with a BMI of at least 30 kg/m², or at least 27 kg/m² with one or more weight-related comorbidities. Its indication for type 2 diabetes is a separate consideration. 

Your doctor may assess your BMI, waist circumference, weight history, existing health conditions, and previous weight-management attempts. They should also consider whether the proposed medicine is appropriate for your circumstances.

Indian obesity guidelines discuss BMI thresholds and metabolic risk in the Indian population. However, clinical guidance does not automatically establish eligibility for every medicine. Your assessment should account for the specific product’s current prescribing information.

What to clarify during your consultation: Whether you meet the criteria for the particular medicine, what health outcomes treatment may help address, and whether other approaches should be considered.

2. Which weight-loss injection is best for me, and why?

The most appropriate injection is not necessarily the one associated with the largest average weight reduction. Different medicines have different mechanisms, dosing schedules, approved indications, potential adverse effects, and costs.

Options your doctor may discuss include:

• Tirzepatide: Acts on both GIP and GLP-1 receptors.
• Semaglutide: Acts on the GLP-1 receptor.
• Liraglutide: Another GLP-1 receptor agonist with a different dosing schedule.

Clinical trials demonstrate that these medicines can support substantial weight loss in eligible patients, but their results should not be interpreted as a direct comparison.

In the STEP 1 trial, participants receiving semaglutide 2.4 mg alongside lifestyle intervention lost an average of 14.9% of their body weight over 68 weeks, compared with 2.4% with placebo. In SURMOUNT-1, average weight reductions with tirzepatide ranged from 15.0% to 20.9% over 72 weeks, depending on the dose, compared with 3.1% with placebo.

Both trials involved adults without diabetes, and they were conducted separately. These averages cannot predict your individual response or establish that one medicine is necessarily better for you.

Your doctor should explain why a particular GLP-1 treatment is being recommended, how the dose will be adjusted, what alternatives are appropriate, and what to do if you experience side effects.

For a detailed comparison, read Tirzepatide vs Semaglutide for Weight Loss.

3. Could my existing health conditions make GLP-1 treatment risky?

Your medical history can influence which medicine is suitable, what precautions are needed and how treatment should be monitored. Disclose your health conditions and all medicines, including over-the-counter products, vitamins and supplements.

Pay particular attention to the following:

• Diabetes: Insulin and certain other glucose-lowering medicines can increase the risk of hypoglycaemia when used with some weight-management treatments. Your doctor may need to adjust your diabetes treatment.
• Digestive and gallbladder conditions: A history of pancreatitis, gallbladder problems or significantly delayed stomach emptying may affect treatment decisions and precautions.
• Kidney health: Existing kidney disease and the risk of dehydration from persistent vomiting or diarrhoea should be discussed.
• Thyroid history: Some products carry specific warnings relating to medullary thyroid carcinoma and multiple endocrine neoplasia syndrome type 2. The applicable restrictions depend on the medicine and its prescribing information.
• Pregnancy plans and breastfeeding: Weight-loss medicines are not appropriate during pregnancy. If you are planning a pregnancy or breastfeeding, discuss medicine-specific guidance and the appropriate timing with your clinician.

Tell your doctor about any previous reactions to weight-loss medication and other significant medical conditions. Do not stop your current medicines or assume that two treatments can be combined safely without medical advice.

The purpose of this discussion is to identify relevant risks before treatment begins, rather than discover them after you have started taking the medicine.

4. Which blood tests do I need before starting GLP-1?

There is no universal blood-test panel that every patient must complete before starting a weight-loss injection. The appropriate assessment depends on your medical history, symptoms, existing conditions, and proposed treatment.

Your doctor may review your weight, BMI, waist circumference, blood pressure, and previous weight-management efforts. Depending on your circumstances, they may also recommend:

Assessment	Why it may be relevant
Blood glucose or HbA1c	To assess blood glucose and identify or monitor diabetes or prediabetes
Lipid profile	To assess cholesterol and triglycerides
Kidney function	When relevant to existing conditions or treatment-related dehydration risk
Liver function	When indicated by your medical history or clinical findings
Other targeted investigations	To investigate specific symptoms or suspected underlying conditions

Thyroid, hormone and other investigations should be guided by clinical indications rather than ordered automatically as a routine weight-loss panel. Baseline measurements also help your doctor evaluate progress and decide whether the treatment plan needs to change. The goal is to identify relevant risks and establish a useful starting point.

Our guide to blood tests for weight loss explains which assessments may be useful when investigating weight-management concerns.

5. How much weight could I realistically lose with a GLP-1 drug?

Clinical trials can help establish realistic expectations, but average results are not a personal forecast. Your response depends on the medicine and dose, treatment duration, tolerability, adherence, other health conditions, and the support accompanying treatment.

Rather than focusing only on a target number of kilograms, discuss what meaningful progress would look like for you.

Your treatment plan should establish:

• A realistic weight-management goal based on your starting point and health.
• When your response will be reviewed.
• How weight, waist circumference, and relevant health markers will be monitored.
• What happens if your weight loss is slower than expected.
• When the clinician might adjust the treatment plan or consider an alternative.

Progress should not be judged by short-term scale fluctuations alone. Improvements in weight-related health conditions and physical function may also matter, depending on your starting health.

Be cautious of promises that you will lose a guaranteed number of kilograms within a fixed period. Individual responses vary, and the appropriate treatment plan may change as your needs evolve.

6. Are weight-loss injections safe, and which side effects should I watch for?

Weight-loss injections can be effective for eligible patients, but they are not risk-free. The potential side effects and precautions depend on the medicine, dose, and your medical history.

Common side effects of GLP-1-based medicines include nausea, vomiting, diarrhoea, constipation, and abdominal discomfort. These symptoms can be more noticeable when treatment begins or the dose increases.

Persistent symptoms should not automatically be dismissed as a normal part of treatment. They can interfere with food and fluid intake and may require a clinical review.

When should you seek medical attention?

Seek prompt medical assessment for severe or persistent abdominal pain, particularly if it occurs with vomiting or spreads to your back. Repeated vomiting, inability to keep fluids down or signs of significant dehydration also need medical attention. Difficulty breathing or swelling of the face or throat requires emergency care.

Before starting, make sure you understand how to administer and store your medicine, what to do if you miss a dose, and whom to contact if symptoms develop. Do not increase, reduce or restart a dose on your own.

The warnings that apply to you will depend on the prescribed product. Your doctor should explain which symptoms can be managed with guidance, which require a medication review and which need urgent care.

For more detail, see our guide to GLP-1 side effects and how long they last.

7. What nutrition, exercise and follow-up support will I need on GLP-1?

Weight-loss injections can help regulate appetite, but they do not replace adequate nutrition, physical activity or medical follow-up. When appetite decreases, it can become harder to consume enough protein and other essential nutrients. Losing weight while maintaining muscle and physical function should therefore be part of the discussion.

Your doctor or nutrition professional can help you establish a practical plan that addresses:

• Nutrition: Getting enough protein and essential nutrients, maintaining adequate fluid intake, and managing symptoms such as nausea or constipation without becoming excessively restrictive.
• Physical activity: Building a manageable activity routine and incorporating resistance exercise where appropriate to support muscle preservation.
• Clinical monitoring: Reviewing your progress, relevant health markers, side effects, and ability to tolerate treatment.
• Ongoing support: Knowing whom to contact if you struggle to eat or drink adequately, experience persistent symptoms or need your treatment plan reviewed.

The World Health Organization’s 2025 guideline on GLP-1 therapies for obesity places these medicines within comprehensive obesity care, alongside healthy eating, physical activity and support from healthcare professionals.

The important consideration is not simply whether a programme provides medication, but whether you have appropriate support to manage your health throughout treatment.

8. What will GLP-1 treatment cost and how long will I need it?

The full cost of weight-loss injections extends beyond the first prescription. Depending on your treatment plan, expenses may include recurring medication costs, consultations, follow-up appointments, recommended tests and nutrition support.

What should you budget for in India?

Before starting, clarify:

• The current cost of your prescribed medicine and dose.
• Whether the cost changes as the dose changes.
• Consultation and follow-up charges.
• The cost of recommended tests and additional support.
• How frequently you will need clinical reviews.

Prices and availability of GLP-1 can change, so confirm current costs with your healthcare provider and a legitimate pharmacy. Avoid choosing a medicine or supplier solely because it is cheaper.

Will you need to continue treatment long-term?

Weight management can require ongoing care. Some people need long-term medication to maintain benefits, while others may need their treatment approach changed because of side effects, cost or other circumstances.

Evidence from the STEP 1 trial extension illustrates why maintenance planning matters. Among a subset of participants who had received semaglutide and lifestyle intervention, substantial weight regain occurred during the year after treatment and the structured lifestyle intervention were discontinued. The study does not predict exactly what will happen to every individual.

Before starting, discuss how long treatment might continue, how your progress will be reviewed, and what alternatives may be available if you cannot tolerate or afford the medicine.

If treatment is discontinued, your appetite and weight trajectory may change. A maintenance plan should address nutrition, physical activity, follow-up and what to do if weight begins to increase again. Do not stop, restart or switch medication without discussing the plan with your clinician.

Before Your Consultation: What Should You Bring?

A little preparation can make your appointment more productive. Consider bringing:

• Your recent weight history and details of previous weight-management treatments.
• A list of your current medicines and supplements.
• Relevant medical reports and recent blood-test results, if available.
• Details of any previous side effects from treatment.
• Your main health goals and concerns.
• Questions about recurring costs, monitoring and long-term care.

You do not need to arrive having already chosen a medicine. Your doctor should help you understand the available options and whether any are appropriate for you.

How EZWeight Can Help You Prepare for Medical Weight Management

Choosing a weight-loss injection should start with an assessment of your health and treatment needs, not a product recommendation based on weight alone.

At EZWeight, our medical weight-management approach includes physician-led assessment, personalised treatment planning, nutrition support and ongoing monitoring. Depending on your circumstances, your care plan may involve medication, lifestyle changes and follow-up reviews.

The aim is to understand your needs, discuss appropriate options and establish how your progress will be evaluated.

Explore EZWeight’s medical weight-loss program to understand the approach and prepare for a discussion about whether medically supervised weight management may be appropriate for you.

The Bottom Line

Before starting weight-loss injections in India, understand why a particular medicine is being recommended, what risks apply to you, how your response will be assessed, what support you will receive and what treatment may cost over time.

The right choice is not necessarily the medicine associated with the biggest weight-loss figure or the lowest upfront price. It is the treatment that is clinically appropriate for you, with a clear plan for monitoring, support and future decisions.

The most important question to leave your consultation with an answer to is: Does this treatment make sense for my health, and do I understand the plan for using it safely?

Frequently Asked Questions

1. Can I buy weight-loss injections online in India?
   
   Prescription weight-loss medicines should be obtained through legitimate, authorised channels and used under appropriate medical supervision. Avoid unverified sellers and products promoted through social media. Your prescribing clinician or registered pharmacist can help you verify the product and its source.
2. Are Mounjaro, Ozempic and Wegovy interchangeable?
   
   No. Mounjaro contains tirzepatide, while Ozempic and Wegovy contain semaglutide. Although Ozempic and Wegovy share an active ingredient, their approved uses, formulations, and dosing instructions differ. The products should not be treated as interchangeable. Always follow the prescribing information for the specific product and your clinician’s advice.
   
3. Should I stop taking weight-loss injections if I experience side effects?

Do not change or stop your prescribed treatment without discussing it with your clinician, unless you are experiencing symptoms that require urgent medical care. Severe abdominal pain, repeated vomiting or other concerning symptoms need prompt assessment. Your doctor can determine whether you need treatment for the symptoms, a dose review or a different approach.

4. Can I take weight-loss injections if I have diabetes?

Not necessarily. Certain medicines have approved indications for chronic weight management in eligible adults without diabetes. However, eligibility depends on the specific medicine, its approved indication and your individual health assessment.

References

1. ESI Clinical Practice Guidelines for the Evaluation and Management of Obesity in India – An Update (2025). PMID: 40917319https://pmc.ncbi.nlm.nih.gov/articles/PMC12410957/
2. Lilly Launches Mounjaro® (tirzepatide), offering a new option for the treatment of obesity and type 2 diabetes
3. Once-Weekly Semaglutide in Adults with Overweight or Obesity. The New England Journal of Medicine. nejm.org/doi/full/10.1056/NEJMoa2032183
4. Tirzepatide Once Weekly for the Treatment of Obesity. The New England Journal of Medicine. https://www.nejm.org/doi/full/10.1056/NEJMoa2206038
5. WHO issues global guideline on the use of GLP-1 medicines in treating obesity. World Health Organization. Guideline on GLP-1 Therapies for Obesity, 2025